LONDON, England—Real-world use of a high-sensitivity cardiac troponin T (hs-cTnT) assay does not lead to diagnostic overuse in patients with suspected ACS, according to results of a registry study ...

A new high-sensitivity blood test for heart attacks successfully diagnosed heart attacks faster and more accurately in the emergency room than the existing test. A new test to assess a whether or not ...

Please provide your email address to receive an email when new articles are posted on . “We anticipate that this procedure will allow many patients with chest pain to be given a ‘yes’ or ‘no’ ...

When Marc Hammer went to the emergency room feeling fatigued and dizzy, he had no idea his life was actually at risk. "I'm an avid cyclist and walk five to 15 miles a day," said Hammer, "so you can ...

When Marc Hammer went to the emergency room feeling fatigued and dizzy, he had no idea his life was actually at risk. “I’m an avid cyclist and walk five to 15 miles a day,” said Hammer, “so you can ...

Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies. The test helps clinicians quickly identify heart attack and ...

Please provide your email address to receive an email when new articles are posted on . Using a novel saliva-based rapid cardiac troponin I test to diagnose MI was feasible, according to the results ...

The newer high-sensitivity troponin test discovers smaller amounts of heart-specific proteins, troponins, than the older troponin test and thus identifies more myocardial infarction patients than ...

This study found that switching from a conventional troponin assay to a high-sensitivity troponin assay resulted in changes to diagnosis patterns and stress testing trends. Objectives: ...

Morton Kern, MD, of VA Long Beach Healthcare System and University of California, Irvine, often engages his colleagues via email in brief, informal dialogue on clinically relevant topics in ...

ABBOTT PARK, Ill., Sept. 25, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its ARCHITECT STAT High Sensitivity Troponin-I blood test has received clearance from the U.S. Food and Drug ...

A group of scientists from the United Kingdom recently discovered that a new blood test can assess whether a person experiencing chest pain is at risk of a heart attack. Over one million people in the ...